Market Research Logo

Advanced Proteome Therapeutics Corp (APC) - Financial and Strategic SWOT Analysis Review

Advanced Proteome Therapeutics Corp (APC) - Financial and Strategic SWOT Analysis Review

Advanced Proteome Therapeutics Corp (APC) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Advanced Proteome Therapeutics Corporation (APC) is a biopharmaceutical company that focuses on the development of anticancer therapeutics that capitalizes on the properties of a natural human protein. It creates, develops and commercializes novel therapies. The company is advancing a site-specific protein modification technology platform for the development of proprietary human protein pharmaceuticals with enhanced therapeutic properties and greater affinity for the target cancer cells and tumors. The patent pending technology combines anti-cancer therapies in a single agent to directly target cancerous tumors and avoid destroying normal cells. The company carries out its operations through its subsidiary; Advanced Proteome Therapeutics Inc. APC is headquartered in Boston, Massachusetts, the US.

Advanced Proteome Therapeutics Corp Key Recent Developments

Jun 18,2018: Advanced Proteome Therapeutics Advances its Technological Capability
Jun 06,2018: Advanced Proteome Therapeutics Names Bill Dickie As Chief Executive Officer, President And Director
May 01,2018: Advanced Proteome Therapeutics Updates its Activities During the 3rd Quarter, FY 2018
Apr 24,2018: Advanced Proteome Therapeutics Announces Appointment of Scientific Advisory Board Members
Apr 16,2018: Advanced Proteome Therapeutics Announces Resignation Of Randal Chase As CEO And Director

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Advanced Proteome Therapeutics Corp - Key Facts
Advanced Proteome Therapeutics Corp - Key Employees
Advanced Proteome Therapeutics Corp - Key Employee Biographies
Advanced Proteome Therapeutics Corp - Major Products and Services
Advanced Proteome Therapeutics Corp - History
Advanced Proteome Therapeutics Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Advanced Proteome Therapeutics Corp - Business Description
Advanced Proteome Therapeutics Corp - SWOT Analysis
SWOT Analysis - Overview
Advanced Proteome Therapeutics Corp - Strengths
Advanced Proteome Therapeutics Corp - Weaknesses
Advanced Proteome Therapeutics Corp - Opportunities
Advanced Proteome Therapeutics Corp - Threats
Advanced Proteome Therapeutics Corp - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Advanced Proteome Therapeutics Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jun 18, 2018: Advanced Proteome Therapeutics Advances its Technological Capability
May 01, 2018: Advanced Proteome Therapeutics Updates its Activities During the 3rd Quarter, FY 2018
Apr 24, 2018: Advanced Proteome Therapeutics Announces Appointment of Scientific Advisory Board Members
Feb 05, 2018: Advanced Proteome Therapeutics Announces New Patent Grant
Jan 31, 2018: Advanced Proteome Therapeutics Announces Anti-Cancer R&D Gathers Momentum
Jan 08, 2018: Heidelberg Pharma and Advanced Proteome Therapeutics Progress Collaborative Program
Jul 31, 2017: Advanced Proteome Therapeutics Announces 2017 AGM Results and Corporate Update
Jul 18, 2017: Advanced Proteome Therapeutics Announces Collaboration to Develop Cancer Therapeutic
May 18, 2017: Advanced Proteome Therapeutics Advances Collaborations
Feb 06, 2017: Advanced Proteome Therapeutics Announces the Appointment of Dr. Randal Chase to Its Executive Leadership Team
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Advanced Proteome Therapeutics Corp, Key Facts
Advanced Proteome Therapeutics Corp, Key Employees
Advanced Proteome Therapeutics Corp, Key Employee Biographies
Advanced Proteome Therapeutics Corp, Major Products and Services
Advanced Proteome Therapeutics Corp, History
Advanced Proteome Therapeutics Corp, Other Locations
Advanced Proteome Therapeutics Corp, Subsidiaries
Advanced Proteome Therapeutics Corp, Key Competitors
Advanced Proteome Therapeutics Corp, Ratios based on current share price
Advanced Proteome Therapeutics Corp, Annual Ratios
Advanced Proteome Therapeutics Corp, Annual Ratios (Cont...1)
Advanced Proteome Therapeutics Corp, Interim Ratios
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Advanced Proteome Therapeutics Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Advanced Proteome Therapeutics Corp, Performance Chart (2013 - 2017)
Advanced Proteome Therapeutics Corp, Ratio Charts
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report